FDA warned www.buyprosoma.com for selling unapproved, misbranded opioids and benzodiazepines to U.S. consumers online.
What happened
FDA reviewed the website www.buyprosoma.com and found it offering unapproved and misbranded opioids and benzodiazepines to U.S. consumers. The letter lists tapentadol, tramadol, alprazolam, clonazepam, diazepam, lorazepam, hydrocodone, and oxycodone, and says FDA has no approved applications for the products offered. FDA also says the site offered prescription drugs without requiring a prescription.
What FDA found
The website sold opioid and benzodiazepine drugs without FDA-approved applications for those products.
FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]The prescription drugs' labeling did not include adequate directions for safe use by a layperson.
FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5The website offered prescription drugs such as hydrocodone and oxycodone without requiring a prescription.
FD&C Act §§ 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]The website caused misbranded drugs to be introduced into interstate commerce.
FD&C Act § 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks www.buyprosoma.com to stop offering any unapproved and misbranded drugs for sale to U.S. consumers and to respond in writing within 15 working days with corrective steps and documentation. If corrections cannot be completed in that time, FDA asks for the reason and a completion date.
Who should pay attention
- online pharmacies selling to U.S. consumers
- companies whose prescription drugs are referenced or copied online
- brands that make or sell opioids or benzodiazepines
This is a summary. Read the original letter on fda.gov.